Abstract Stimulation of osteoblast proliferation and differentiation is important for the in vivo bone-bonding ability of biomaterials. Previous in vitro studies have used biochemical assays to analyze osteoblast-specific gene expression in cultured osteoblasts. In this study, we generated transgenic mice harboring a monomeric red fluorescent protein 1 transgene under the control of a 2.3-kb fragment of the Col1a1 promoter, which is active specifically in osteoblasts and osteocytes. We established a fluorescent primary osteoblast culture system to allow noninvasive observation of osteoblast proliferation and differentiation on opaque materials in vitro. We used this system to evaluate alkali-and heat-treated titanium, which has a strong bone-bonding ability in vivo, and we observed a rapid increase in fluorescence intensity and characteristic multifocal nodule formation. A cell proliferation assay and RT-PCR to examine osteoblast-specific gene expression showed increased osteoblast proliferation and differentiation consistent with the fluorescence observations. This mouse model allowed us to use fluorescence intensity to visualize and quantify in vivo newly formed bone around implanted materials in femurs. The use of these fluorescent osteoblasts is a promising method for simple screening of the bone-bonding ability of new materials.
Introduction
Various biomaterials are available for joint implants, bone substitutes, and fixation devices. Many alloys and surface treatments have been developed to improve their affinity with bone tissue. The bone-bonding ability of these biomaterials is usually evaluated using animal experiments in which the biomaterial of interest is implanted into bones of large animals, such as dogs and rabbits, the bonding force is measured mechanically using a detaching test [1] , and the material-bone interface is evaluated histologically. In practical terms, large animal experiments are the most valid method for predicting outcomes in humans. However, because of the high cost of the animals, long experimental periods, and time-consuming assay procedures, such models are not ideal for screening a large number of new biomaterials.
To overcome these problems, in vitro methods have been introduced to measure proliferation and osteoblastic differentiation of cultured cells on biomaterials. However, there remain several drawbacks. First, to evaluate osteoblastic differentiation by analyzing osteoblast-specific marker genes and protein levels, cell cultures need to be stopped at each examination time point, and this hampers time-lapse observations of the same sample. Second, the cultured cells do not differentiate uniformly on the material of interest, and the positional information is inevitably lost by homogenization of the cells to extract proteins and mRNA. Third, because most biomaterials are not translucent, cells growing on the material cannot be visualized using standard light microscopy. Fourth, most of the biochemical assay procedures are cumbersome and require many reagents and complex equipment, which introduce the potential risk of contamination and technical errors.
In this study we established a new evaluation system to: (1) simplify the in vitro assay procedure to facilitate highthroughput screening and (2) enable serial evaluation of cell differentiation on the same metal sample without losing positional information.
Fluorescent proteins are used widely in noninvasive imaging of living cells. Fluorescence imaging systems are useful in the field of biomaterial evaluation because the opacity and the surface roughness of most biomaterials prevent the use of light microscopy to obtain focused images. High-resolution images from selected depths can be obtained using fluorescence bioimaging with a confocal laser scanning microscope. Several applications of fluorescence bioimaging technology for biomaterial evaluation have been reported. Blum et al. [2] used a rat fibroblastic cell line transfected by retroviral vectors harboring enhanced green fluorescent protein (eGFP) and luciferase expressed through the cytomegalovirus promoter to visualize cells seeded in a hydrogel material and on titanium fiber mesh. Xia et al. [3] visualized cell survival in scaffolds after in vivo implantation of human mesenchymal stem cells transfected by retroviral vectors encoding eGFP. These methods are useful for evaluating cell shapes and numbers on materials but they do not provide information about the differentiation status of the cells. To visualize the differentiation of cells grown on biomaterials, it is necessary to restrict the expression of fluorescence to specific stages of cell differentiation. The 2.3-kb fragment of the promoter of Col1a1 is an osteoblast-specific promoter which was reported by Dacic et al. [4] to become active specifically in differentiated osteoblasts and osteocytes [5] . In this study, we generated transgenic mice harboring a monomeric fluorescent protein 1 (mRFP1) transgene under the control of the Col1a1 2.3-kb promoter (Col1a1(2.3 kb)-mRFP1 mice). Using calvarial osteoblasts harvested from this mouse line, we established a primary osteoblast culture system to visualize osteoblast differentiation on biomaterials.
To validate this system using fluorescent osteoblasts, we evaluated alkali-and heat-treated titanium as a positive control because this surface treatment improves the bonebonding ability of titanium metal. We have reported excellent bone-bonding ability with this treatment evaluated by mechanical tests using large animals [6] and favorable clinical outcomes of hip implants that have received this treatment [7] . Enhanced osteoblastic differentiation of osteoblasts on titanium plates after alkali and heat treatment has been reported by Isaac et al. [8] .
By analyzing the fluorescent images obtained longitudinally from the same samples, we quantified fluorescence as an indicator of gene expression and the development of mineralized nodules. This system revealed a rapid increase in fluorescence intensity and a characteristic multifocal developmental pattern of calcified nodules in cells grown on alkali-and heat-treated titanium plates. We performed in vivo evaluations of alkali-and heat-treated titanium used in transgenic mice, and we obtained results similar to those obtained from our in vitro evaluation. This is the first report to show: (1) the in vitro and in vivo use of a fluorescence bioimaging system established from transgenic mice harboring an mRFP1 transgene under the control of the osteoblast-specific 2.3-kb fragment of the Col1a1 promoter for biomaterial evaluation and (2) the pattern of longitudinal nodule development on biomaterials using images obtained noninvasively from the same samples.
Materials and methods

Preparation of titanium materials
Commercially pure (99.5 %) titanium (CpTi) plates (Nilaco Co., Tokyo, Japan) were cut to the sizes of 18 9 18 9 1 mm for 6-well culture plates and 14 9 14 9 1 mm for 12-well culture plates, and the titanium plates were polished with number 400 diamond plate. Alkali-and heattreated titanium (AhTi) samples were produced as described previously [6] . Briefly, titanium plates were soaked in 5 M NaOH at 60°C for 24 h and subsequently heated at 600°C for 1 h. The previously reported mean average surface roughness (Ra) and maximum roughness (Rmax) of the titanium plates were 0.32 and 3.63 lm for CpTi, and 0.35 and 4.13 lm for AhTi, respectively [9] . For in vivo experiments, pure titanium wires with a diameter of 0.6 mm (Nilaco Co.) were used. All samples were sterilized in ethylene oxide gas before use. Photographs of these materials are shown in Fig. 1a , b.
Scanning electron microscopy
The materials were observed using a field-emission scanning electron microscope (SEM) (S-4700; Hitachi Ltd., Tokyo, Japan) at an acceleration voltage of 5 kV. The SEM images of the samples are shown in Fig. 1c-h . To observe the cells on the materials, 2 days after seeding mouse calvarial osteoblasts on CpTi and AhTi plates, the cells were fixed in 2 % glutaraldehyde for 1 h. The plates were rinsed gently with 0.1 M phosphate buffer at pH 7.2, dehydrated in an ethanol series, frozen in tert-butyl alcohol, freeze-dried, and sputter-coated with gold and palladium. Animals C57BL/6 transgenic mice harboring the mRFP1 gene under the control of the 2.3-kb Col1a1 promoter fragment (Col1a1(2.3 kb)-mRFP1 mice) were created (Fig. 2a) . Genotyping was performed by PCR using the primers 5 0 -TCC CCGACTACTTGAAGCTG-3 0 and 5 0 -CTTGGCCATGTAG GTGGTCT-3 0 , which amplify 317 bp of mRFP1 (Fig. 2b) . The animal care and experimental procedures used were approved by the Animal Research Committee, Kyoto University, and were performed according to the Regulation on Animal Experimentation at Kyoto University.
Cell culture
Primary mouse calvarial osteoblasts were harvested from the calvaria of 1-to 5-day-old neonatal transgenic mice using a modification of a previously described protocol [10] . Calvarial bone fragments were subjected to five sequential 15-min digestions in medium containing 0.1 % collagenase P (Roche Applied Science, Indianapolis, IN, USA) and 0.00125 % trypsin (Sigma-Aldrich, St. Louis, MO, USA), and cell fractions 3-5 were collected. Cells were seeded at a density of 3 9 10 5 and 1 9 10 5 cells/well in 6-and 12-well tissue culture polystyrene plates, respectively, containing the titanium plates on the bottom. Cells were grown in osteogenic medium comprising DMEM (Sigma-Aldrich) supplemented with 10 % fetal bovine serum (Tissue Culture Biologicals, Long Beach, CA, USA), 10 mM b-glycerophosphate (Sigma-Aldrich), 80 lg/ml ascorbic acid (SigmaAldrich), and 10 -8 M dexamethasone (Sigma-Aldrich) at 37°C in a humidified atmosphere of 5 % CO 2 and 95 % air. The culture medium was replaced every other day.
Confocal laser scanning imaging of cell cultures
Fluorescence imaging of cultured cells was performed every 4 days after seeding until day 28. Fluorescence images were obtained with a confocal laser microscope (Nikon Instruments Inc., Tokyo, Japan). mRFP1 was excited using a 543 nm laser and detected through a 590/50 nm band-pass filter. For each sample, one low-magnification (29) field image and nine high-magnification (109) field images were captured in 512 9 531 pixels. The experiment was repeated three times, and the pinhole setting and contrast gain were maintained for all scans at the same magnifications. The images were analyzed using NIH ImageJ free software available at http://rsb.info.nih.gov/nih-image/. The number of red pixels was counted in each sample. The threshold was maintained for all images. The intensity of mRFP1 expression (total fluorescent area) was defined as the total number of red pixels from nine high-magnification (109) fields. Red fluorescent spots of [10 pixels in lowmagnification images (29) were considered to be calcification nodules, and the number and the size of nodules were analyzed using the ''Analyze Particle'' function of ImageJ. sulfophenyl)-2H-tetrazolium-5-carboxanilide] reduction assay was performed as described previously [11] . Briefly, 500 ll of XTT working solution was added to each well, the cells were incubated at 37°C for 6 h, and the absorbance was measured on a microplate reader (Thermo LabSystems, Cheshire, UK). Specific absorbance was calculated as follows: specific
RT-PCR Total RNA was extracted using the RNAeasy Mini Kit (Qiagen, Hilden, Germany) according to the Surgical procedure
Ten-week-old male Col1a1(2.3 kb)-mRFP1 mice were anesthetized by intraperitoneal injection of pentobarbital sodium (40 mg/kg). The lateral thigh and knee joint were incised, and the knee joint was opened by medially dislocating the patella. A hole was drilled into the intercondylar fossa with a 23-G needle, and a treated or untreated titanium wire was tapped from the hole into the medullary cavity until it broke through the cortex of the greater trochanter. Both ends of the wire were bent and trimmed, and the knee joint and skin were sutured after reducing the patella.
Imaging of mRFP1 fluorescence of the intramedullary wires
Mice were killed 28 days after the implantation. The distally protruding wire was cut and the rest of the wire was pulled out proximally. From the distally cut end, 2 mm was excluded, and the remaining 8 mm was set as the region of interest. Fluorescence images were obtained just after wire removal using a stereomicroscope (SZX12; Olympus, Tokyo, Japan) equipped with a fluorescent lamp system with the same conditions and exposure time. For each wire, the entire circumference was captured in two images taken from the top and the bottom. The number of red pixels on the wire was counted.
Histological examination
Twenty-eight days after implantation, the mice were killed and the right femur was removed, fixed in 10 % phosphate-buffered formalin (pH 7.25) for 7 days, and dehydrated in an ethanol series. The specimens were then embedded in EpoFix Resin (Struers, Ballerup, Denmark) and cut with a band saw (BS-3000CP; EXACT cutting system, Norderstedt, Germany) perpendicular to the longitudinal axis of the femur. For each sample, three sections were chosen (subtrochanteric, middle shaft, and supracondylar regions). The sliced samples were ground to a thickness of 40-60 lm using a grinding-sliding machine (microgrinding MG-4000; EXACT). The sections were stained with Van Gieson's picrofuchsin [12] . The ratio of bone contact relative to the total perimeter of the implant was defined as the affinity index and was quantified using ImageJ.
Statistical analysis
The data are presented as the mean ± SD and were assessed using Student's t test to compare two groups. Differences with p \ 0.05 were considered significant.
Results
Specific expression of red fluorescence was observed in vivo in bone tissues and in vitro in differentiated osteoblasts
To verify the tissue specificity of mRFP1 expression, fluorescent images were obtained in neonatal mice. Images of forelimbs of a 7-day-old transgenic mouse using light and fluorescence microscopy are shown in Fig. 2c . Red fluorescence in the limb skeleton was observed through the skin of the transgenic mouse. The calvarial bone showed a high level of expression of mRFP1 (Fig. 2d) . Each osteoblast was visualized in the calvaria using a confocal laser microscope (Fig. 2e, f) . Macrofluorescence photography and observations of frozen sections of an exposed femur of a 3-week-old transgenic mouse showed no fluorescence in the growth plate and articular cartilage (Fig. 2g, h ). The sustained expression of mRFP1 was confirmed in a 10-month-old transgenic mouse (Fig. 2i) .
To confirm this transgene expression in culture, cultured osteoblasts were observed with fluorescence imaging. Figure 2j , k shows images obtained using light and fluorescence microscopy to observe cultured osteoblasts in a polystyrene culture dish on day 16. Red fluorescence was observed mainly in areas dense with osteoblasts. Serial observation of osteoblasts on titanium plates using confocal microscopy showed that fluorescence became detectable around culture day 7 and the fluorescent area increased progressively over time (Fig. 2l) .
Osteoblasts grown on AhTi plates expressed red fluorescence in a larger area throughout the observation period compared with those grown on CpTi plates
To visualize the time course and spatial distribution of osteoblast proliferation and differentiation on the biomaterials used in this culture system, serial images of the same sample sets were obtained over 4 weeks (Fig. 3a) . As shown in Fig. 3b , the fluorescent area began to increase on culture day 16 on both materials. The fluorescent area on day 16 was three times larger on AhTi plates (1.65 9 10 5 ± 3.87 9 10 4 pixels) than on CpTi plates (4.39 9 10 4 ± 4.45 9 10 4 pixels), and this difference continued throughout the observation period. However, the average daily increase in the total fluorescent area between days 16 and 24 was 5.70 9 10 4 pixels/day for CpTi plates and 5.68 9 10 4 pixels/day for AhTi plates, which did not differ between materials.
Multifocal nodule formation was observed on AhTi plates
The nodule numbers counted as fluorescent spots in lowmagnification images are shown in Fig. 3c , and the average sizes of these nodules are shown in Fig. 3d . On day 16, the nodule number was three times higher in the AhTi plates (66.7 ± 9.45) than in the CpTi plates (17 ± 6.93) (p \ 0.05). By contrast, the average nodule size was 1.5 times larger in the AhTi plates (110 ± 1.21) than in the CpTi plates (73.3 ± 061) (p \ 0.05). To gain an overview of nodule development, the distribution of the sizes and numbers of nodules in a sample is shown in Fig. 3e . There were more small nodules in the AhTi plate throughout the observation period (Table 1) . These results indicate that AhTi plates accelerated the onset of differentiation, but once the process had started the progression was less affected by the treatment. plates. These differences in shape reflect differences in the surface characteristics of the materials. The results of the XTT analysis of cell number are shown in Fig. 4b . On day 2, the mean absorbance was 60 % higher for AhTi plates (0.201 ± 0.0352/cm 2 ) than for CpTi plates (0.121 ± 0.0393/cm 2 ) (p \ 0.05). However, no significant difference was observed on days 7 day 16, indicating that AhTi treatment promoted cell adhesion and proliferation, which were related to the accelerated onset of fluorescence expression on AhTi plates.
Osteoblast-specific gene expression levels were determined using RT-PCR on days 2, 7, 14, and 16 ( Fig. 4c) . Alp expression increased throughout the observation period for cells grown on both materials. The cells on AhTi plates had a non-significantly higher Alp expression level on day 7 (p = 0.06), day 14 (p = 0.06), and day 16 (p = 0.06) than cells grown on CpTi plates. Ocn expression increased on day 14 for both materials. These results are compatible with the finding that the fluorescence expression driven by the Col1a1 2.3-kb promoter started increasing around day 16. Although the expression levels were low, significantly higher Ocn expression levels were observed on AhTi plates on day 2 (p \ 0.05) and day 7 (p \ 0.05) compared with those observed on CpTi plates. Col1a1 expression for both materials increased throughout the observation period, but its expression did not differ significantly between CpTi and AhTi plates (day 2, p = 0.51; day 7, p = 0.62; day 14, p = 0.27; day 16, p = 0.79).
Bone formation around the materials was visualized and quantified in the in vivo system Next, to assess the application of this system for in vivo evaluation of materials, we quantified the newly formed bone around the intramedullary materials in the fluorescence images. The gross appearance of the operative procedure and an X-ray image of the implanted wire are shown in Fig. 5a , b. Twenty-eight days after implantation, the wires were removed and fluorescence images were obtained (Fig. 5c) . The fluorescent area was five times larger for the AhTi wires than the CpTi wires (Fig. 5d) . Newly formed bone was also quantified using the affinity indexes obtained from histological sections stained with Van Gieson's picrofuchsin (Fig. 5e) . The affinity index was 60 % higher for AhTi wires (46.1 ± 22.9 %) than CpTi wires (27.9 ± 33.5 %). These results are compatible with the fluorescence observations (Fig. 5f ).
Discussion
Several noninvasive bioimaging techniques for visualizing osteoblast differentiation have been reported. Iris et al. [13] reported a bioluminescence imaging method for visualizing differentiation of bone marrow-derived mesenchymal stem cells to osteoblasts in transgenic mice harboring the firefly luciferase gene under the control of the human osteocalcin promoter (hOC). They also reported the time course of the expression of luciferase during in vivo skeletal development and bone repair. Expression of the hOC promoter is restricted to fully differentiated osteoblasts. However, in the field of material evaluation, a broader range of differentiation stages is preferable for imaging, and bioluminescence imaging is inadequate for obtaining highresolution images. Kuhn et al. [5] reported a fluorescence imaging system for observing osteoblasts from transgenic mice harboring the GFP transgene under the control of the 2.3-kb fragment of the Col1a1 promoter cultured on carbonated hydroxyapatite-coated disks. In this study, we used mRFP1 instead of GFP because of its greater tissue penetration and spectral separation from autofluorescence and other fluorescent proteins [14] , which enabled us to perform additional in vivo evaluation of the materials free of background fluorescence. mRFP1 is a true monomeric variant of the red fluorescent protein DsRed isolated from Discosoma sp. In contrast to DsRed, which is known to affect embryonic stem cell development due to its obligate tetramerization [15] , the safety of mRFP1 has been well established. Transgenic mice with a ubiquitously high expression of mRFP1 have been reported to show no difference from their non-transgenic littermates in embryonic development, adult organ maturation [16] , and neural and muscular functions [17] . The irradiation damage caused by a laser to induce fluorescence may be of concern. However, scanning electron microscopic observation of cochleas stained with fluorescent dyes after laser irradiation using confocal laser microscopy showed no cellular or ultrastructural damage at a normal laser intensity [18] . Therefore, fluorescence imaging using mRFP1 may be a suitable method for the noninvasive imaging of living cells. Another report involved imaging of alkaline phosphatase activity using a fluorinated ALP substrate detected with 19 F magnetic resonance spectroscopic imaging after hydrolysis [19] . Although this method is a useful noninvasive method of visualizing osteoblasts, it requires special reagents and analytical equipment.
Formation of a calcified extracellular matrix is an obvious indicator of osteoblast maturation. Quantification of calcified nodules is often used to evaluate the in vitro bone-bonding ability of biomaterials [20] . Several techniques for detecting nodules or mineral deposition on opaque materials have been reported. They include histological methods (von Kossa or Alizarin Red S staining), fluorescence labeling (tetracycline, calcein blue, etc.) [21, 22] , detection of the crystalline structure of calcium phosphate using X-ray diffractometry, Fourier transform infrared spectrometry (FTIR) [23] , and scanning electron microscopy [24, 25] . Histological analysis is easy and has been used for decades. However, except for FTIR, none of these techniques can distinguish cellmediated calcification from spontaneous precipitation of calcium phosphate in degraded tissues. In this study, the fluorescent substance was produced by transgenic mice, and the fluorescence detected from nodules definitely reflected cell-mediated calcification. Our method may be the first valid method for detecting cell-mediated calcification.
We performed serial observation of the same sample and found that materials with bone-binding ability showed multifocal development of nodules from the time of the initial formation but that the rate of the increase in size of the nodules did not differ between the materials. Maeda et al. [22] reported their noninvasive observations of nodule formation and quantified the time-dependent increase in green fluorescent emission from calceinlabeled nodules formed by rat mesenchymal stem cells cultured in osteogenic medium supplemented with calcein. However, they did not evaluate the characteristics of individual nodules. Our study is the first to quantify the change in both nodule number and average size with time in cells grown on biomaterials. We found a difference in the pattern of nodule formation between materials according to their bone-bonding ability. AhTi plates had accelerated growth and multifocal nodule formation. In large animal experiments, the application of alkali and heat treatment accelerates the increase in failure load in detaching tests [6] . The failure load of alkali-and heattreated implants was significantly higher than that of control titanium implants at 4 weeks. Although further studies on other bone-bonding biomaterials are required, the acceleration of an increase in failure load in vivo may be explained by accelerated multifocal bone-material bonding, which is represented as multifocal nodule formation in vitro.
In this study, we also used fluorescence images to quantify new bone formation around the biomaterial in vivo. Compared with conventional histological evaluation, this technique is easy to perform and requires no sample preparation before observation. The bone-bonding ability of biomaterials has not been evaluated in transgenic animals with an introduced fluorescent marker gene. This may be because the genetics of large animals commonly used in biomaterial evaluation have not been well studied and gene-modified animals are not available. Although mice are too small to undergo mechanical tests, our in vivo experimental model is useful for confirming the results of an in vitro culture system and may be a promising modality for the in vivo study of biomaterials.
Lastly, from the point of animal welfare, this system may help reduce the number of animals needed for experimental work. Evaluating the same sample repeatedly would require fewer samples and cells, and hence fewer neonatal mice. Establishment of an osteoblastic cell line from this transgenic mouse could reduce the number of experimental animals needed for research even further.
In conclusion, we performed noninvasive serial observations of osteoblast proliferation, differentiation, and nodule formation on biomaterials. This system may be a promising method for screening and studying the bonebonding ability of biomaterials.
